Ovid Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$2.44

+0.01 (+0.41%)

As of Oct 3, 2:18 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +1,582.0% upside

Low Target $30.97

Average Target $41.04

High Target $66.83

Current Price $2.44

Current
$2.44

Target
$41.04

$30.97 $41.04 avg $66.83

Scenario Analysis

Bear Case

$30.97

1,169.3%

Low target

Base Case

$41.04

+1,582.0%

Avg target

Bull Case

$66.83

+2,638.9%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$3.11

-21.4% from high

52-Week Low

$1.18

+106.8% from low

Target vs 52W High

$41.04

+1,221.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.0%
AMGN Amgen Inc	Hold	43	47%	$190.87	-52.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+150.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-21.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.8%